Cambridge Innovation Center

JETRO Partners with Top Accelerators to Launch “Global Startup Acceleration Program”

Retrieved on: 
Thursday, September 14, 2023
Professional Services, Public Policy, Government, Business, Other Professional Services, Other Policy Issues, Start-Up, GSAP, Travel, Marketing, MIT Global Startup Workshop, JETRO, Multimedia, Japan External Trade Organization, Cambridge Innovation Center, Berkeley SkyDeck, Draper University, Growth, Ecosystem, City, METI, Video game

The Japan External Trade Organization (JETRO), with the support of the Government of Japan’s Cabinet Office, will launch this year’s Global Startup Acceleration Program (GSAP) in September.

Key Points: 
  • The Japan External Trade Organization (JETRO), with the support of the Government of Japan’s Cabinet Office, will launch this year’s Global Startup Acceleration Program (GSAP) in September.
  • The acceleration program will focus on supporting the overseas expansion of Japanese startups.
  • Five courses will be conducted exclusively in English, and JETRO will provide support for global expansion to each startup according to the needs of each company.
  • The Global Startup Acceleration Program (GSAP) – formerly known as the Startup City Acceleration Program – was originally founded in 2020 to help facilitate the growth and expansion of Japanese startup ecosystems.

Tunnell Consulting Expands its Presence with New Headquarters in Berwyn, Pennsylvania

Retrieved on: 
Thursday, August 3, 2023
Heart, Research, CIC, Cambridge Innovation Center, Philadelphia Main Line, Growth, Government, Tunnell, Pharmaceutical industry, Fine chemical

BERWYN, Pa., Aug. 3, 2023 /PRNewswire-PRWeb/ -- Tunnell Consulting, an organization that provides expert talent and consulting services to emerging and mid-sized life sciences companies, government agencies and nonprofits, announced today that it has moved its headquarters to Berwyn, Pennsylvania, marking a significant milestone in the company's growth and reinforcing the firm's commitment to both Pennsylvania and Massachusetts as centers for the life sciences industry and research. The opening of the new office was marked with a ribbon-cutting ceremony. The new office adds an important regional hub to the company's other location at the Cambridge Innovation Center in Cambridge, Massachusetts; and Tunnell Government Services in Bethesda, Maryland. In business for over 60 years, Tunnell has delivered consistent support and talent to both emerging and mid-size biopharma companies and government agencies with a high-value, flexible approach to support the entire development lifecycle.

Key Points: 
  • The new office adds an important regional hub to the company's other location at the Cambridge Innovation Center in Cambridge, Massachusetts; and Tunnell Government Services in Bethesda, Maryland.
  • "This expansion represents an important milestone for Tunnell, as we continue our expansion with footprints in the region's most important life science hubs," said Maryann Gallivan, President and CEO of Tunnell Consulting.
  • "Pennsylvania has a thriving community of pharmaceutical and life sciences professionals.
  • Tunnell Consulting supports some of the world's leading pharmaceutical, biotech and vaccine firms, as well as emerging and startup companies.

Sanyou launches new European offices and continues to promote global business landscape

Retrieved on: 
Saturday, June 3, 2023
Heart, Shard, Intelligence, The Gateway of Europe, CIC, CDO, Cambridge Innovation Center, R, The Shard, CPO, D, Fine chemical

Headquartered in Shanghai China, Sanyou Biopharmaceuticals Co., Ltd. is a world-leading national high-tech biotechnology enterprise focusing on R&D and services of innovative biological drugs.

Key Points: 
  • Headquartered in Shanghai China, Sanyou Biopharmaceuticals Co., Ltd. is a world-leading national high-tech biotechnology enterprise focusing on R&D and services of innovative biological drugs.
  • At present, Sanyou has established a world-leading core technology platform for integrated R&D and preclinical development of innovative biological drugs, and possesses a world-class "super-trillion innovative-drug lead molecule library".
  • The company have penetrated in the market through its "4C" business service (differentiated CRO, integrated CDO, collaborative CPO, and characteristic CRS).
  • Sanyou has established business partnerships with more than 600 pharmaceutical companies, drug R&D institutions, and diagnostic reagent and product development companies worldwide.

Cumulus Neuroscience Receives FDA 510(k) Clearance for Award-Winning, First-In-Class Neurophysiology Platform for At-Home Use

Retrieved on: 
Thursday, May 4, 2023
Bracco, Gilead Sciences, Drug development, CV, Hope, CCO, CNS, CIC, Neurophysiology, UKCA, Acquisition, Cambridge Innovation Center, Patient, Central nervous system disease, EEG, Adolescence, Alivecor, United Kingdom, Growth, Diagnosis, Ecosystem, FDA, Health, Medivation, Therapy, Medical device, MD, Cumulus cloud, Pfizer

BELFAST, Northern Ireland and CAMBRIDGE, Mass., May 4, 2023 /PRNewswire/ -- Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data, today announced that its novel, award-winning dry-sensor EEG headset, has been granted 510(k) clearance from the United States Food and Drug Administration (FDA). This represents the second medical device clearance for the headset, which previously received the UK Conformity Assessed (UKCA) mark in the United Kingdom.  

Key Points: 
  • This represents the second medical device clearance for the headset, which previously received the UK Conformity Assessed (UKCA) mark in the United Kingdom.
  • This groundbreaking technology provides a means to initiate clinical studies remotely with data transmitted to the Cumulus Medical Device Hub, allowing healthcare professionals to review EEG recordings in real-time.
  • The company's 510(k) clearance comes on the heels of its appointment of Tina Sampath as Chief Commercial Officer (CCO).
  • Cumulus supports precision in CNS clinical trials for its industry partners by enabling remote monitoring of patients across multiple domains of brain function.

Cumulus Neuroscience Receives FDA 510(k) Clearance for Award-Winning, First-In-Class Neurophysiology Platform for At-Home Use

Retrieved on: 
Thursday, May 4, 2023
Bracco, Gilead Sciences, Drug development, CV, Hope, CCO, CNS, CIC, Neurophysiology, UKCA, Acquisition, Cambridge Innovation Center, Patient, Central nervous system disease, EEG, Adolescence, Alivecor, United Kingdom, Growth, Diagnosis, Ecosystem, FDA, Health, Medivation, Therapy, Medical device, MD, Cumulus cloud, Pfizer

BELFAST, Northern Ireland and CAMBRIDGE, Mass., May 4, 2023 /PRNewswire/ -- Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data, today announced that its novel, award-winning dry-sensor EEG headset, has been granted 510(k) clearance from the United States Food and Drug Administration (FDA). This represents the second medical device clearance for the headset, which previously received the UK Conformity Assessed (UKCA) mark in the United Kingdom.  

Key Points: 
  • This represents the second medical device clearance for the headset, which previously received the UK Conformity Assessed (UKCA) mark in the United Kingdom.
  • This groundbreaking technology provides a means to initiate clinical studies remotely with data transmitted to the Cumulus Medical Device Hub, allowing healthcare professionals to review EEG recordings in real-time.
  • The company's 510(k) clearance comes on the heels of its appointment of Tina Sampath as Chief Commercial Officer (CCO).
  • Cumulus supports precision in CNS clinical trials for its industry partners by enabling remote monitoring of patients across multiple domains of brain function.

Cumulus Neuroscience Expands Development Support of Novel Precision CNS Therapeutics

Retrieved on: 
Tuesday, April 11, 2023
Cognition, Drug development, Therapy, Sunovion, Brain, Language, CNS, CIC, Central nervous system, Neurophysiology, Cambridge Innovation Center, Patient, EEG, Ecosystem, Health, Memory, Caregiver, Pharmaceutical industry, Nursing, MD, Cumulus cloud

BELFAST, Northern Ireland and CAMBRIDGE, Mass., April 11, 2023 /PRNewswire/ -- Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data, today announced the establishment of new Cumulus offices in the Boston area to support its expanding partnerships with biopharma innovators. The new Cambridge Innovation Center (CIC) location, in the leading life sciences hub, will help foster existing and future collaborations across diverse aspects of Central Nervous System (CNS) innovation, and deepen the company's presence in North America.

Key Points: 
  • Growing Biopharma Partnerships Underscore Company Commitment to Accelerate Neuroscience Precision Medicine Innovation; New Boston-Area Offices Establish U.S.
  • Presence
    BELFAST, Northern Ireland and CAMBRIDGE, Mass., April 11, 2023 /PRNewswire/ -- Cumulus Neuroscience (Cumulus; The Company), a global digital health company focused on advancing neuroscience clinical trials and patient care through improved data, today announced the establishment of new Cumulus offices in the Boston area to support its expanding partnerships with biopharma innovators.
  • "Cumulus is driven to become the preferred precision CNS drug development partner for biopharma innovators developing cutting-edge therapeutics, and our presence in Cambridge serves to support both existing and expanding collaborations – which, we hope, will ultimately advance the CNS ecosystem for the benefit of patients," said Aman Bhatti, MD, CEO, Cumulus Neuroscience.
  • The establishment of the Cumulus Boston-area presence will help strengthen the Company's collaborations with Massachusetts-based companies, including Sunovion Pharmaceuticals.

CIC Health Elevates Rachel Wilson to Chief Executive Officer

Retrieved on: 
Friday, January 13, 2023
Data Management, Public Policy, Government, Health, Healthcare Reform, Technology, Other Technology, General Health, Health administration, Rowe, COVID, CIC, Gillette Stadium, University, Occupational therapy, COVID-19, Master of Health Administration, Infection, Learning, Public health, Safety, Commonwealth, Cambridge Innovation Center, Wilson, Vaccine, Hynes Convention Center, Organization, Aspen Institute, Atrius Health, University of North Carolina at Pembroke, Elizabethtown College, Chapel Hill, Management, Pharmaceutical industry

CIC Health, a public health company, today announced that its Board has elevated Rachel Wilson to the role of Chief Executive Officer.

Key Points: 
  • CIC Health, a public health company, today announced that its Board has elevated Rachel Wilson to the role of Chief Executive Officer.
  • “Rachel joined CIC Health’s leadership team during a pivotal time in the pandemic, before we even had approved vaccines.
  • Rowe continues to serve as the CEO of the Cambridge Innovation Center (CIC), the innovation campus operator which spun out CIC Health.
  • Prior to her role at CIC Health, Wilson served as the Chief Operating Officer at Atrius Health where she provided overall strategic direction and operational oversight for clinical service lines.

Gillette Stadium Adds Sustainable Reuse Program Through Unique Partnership with WIN Waste Innovations

Retrieved on: 
Tuesday, September 20, 2022
Revolution, Cambridge Innovation Center, COVID-19, Twitter, Patriot, Recycling, NHL Winter Classic, NCAA, NHL, View, Partnership, Billboard, COO, Environment, NFL, Waste, Natural Resources, CEO, New England Revolution II, Instagram, Gillette Stadium, Gillette, Solution, Plastic, Collection, Waste management, Paper, New England Revolution, Multimedia, Health, New England Patriots, Natural gas, Metal, Coal, 2020 New England Patriots season, Facebook, Pollstar

PORTSMOUTH, N.H., Sept. 20, 2022 /PRNewswire/ -- When the New England Patriots take the field in Foxborough this month, they'll have a new ally working behind the scenes to make the home game experience great. WIN Waste Innovations is bringing its curb-to-grid waste-handling model to professional sports in New England. In partnership with Gillette Stadium, the New England Patriots, and the New England Revolution, the company will collect, handle, and process the trash and recyclables generated at the stadium in a way that lessens its environmental impact and converts waste to renewable energy.

Key Points: 
  • Gillette Stadium will divert 642+ tons of waste from landfills through a new partnership with WIN Waste Innovations.
  • "We are excited to help Gillette Stadium advance its sustainability strategy while delivering industry-leading waste and recycling services to the stadium," said Bob Boucher, CEO of WIN Waste Innovations.
  • With the WIN Waste partnership, Gillette will now reduce its environmental impact even more by converting postrecycled waste into renewable power.
  • WIN Waste Innovations is a sustainable waste management company committed to delivering essential waste management solutions to customers and communities.

Cirrus Aircraft Unveils 189,000-Square-Foot Duluth Innovation Center Dedicated to Revolutionizing Personal Aviation

Retrieved on: 
Monday, September 19, 2022
Luxury, Air, Engineering, Transport, Aerospace, Manufacturing, Transportation, Retail, Travel, Aircraft, Culture, Safety, Engineering, Vision, Cirrus Airframe Parachute System, Row equivalence, FAA, Cambridge Innovation Center, KDLH, Tenant, CAPS, Sale, Northwest Airlines, Duluth International Airport, Acquisition, Life, Aviation, Maintenance, Investment, History, City, Economic development, Ownership, Innovation Center station, Ecosystem, AAR Corp, Multimedia, Jet, Innovation, Subject, Airline, Cirrus Aircraft, Cirrus

(Photo: Business Wire)

Key Points: 
  • (Photo: Business Wire)
    Cirrus Aircraft will invest heavily to transform the 189,000-square-foot building on 39 acres into a state-of-the-art Innovation Center where engineers will develop the next generation of Cirrus aircraft.
  • The Duluth Innovation Center will feature amenities and flexible workspaces that enhance the working environment as people return to the office.
  • We want talent to think of Cirrus Aircraft, Duluth, and now the new Innovation Center as a special place where the latest and greatest general aviation technologies come to life.
  • From the founding days of Cirrus Aircraft in the basement of a Wisconsin barn to the new Innovation Center, the company has maintained a rich culture of innovation that has changed personal aviation, said Pat Waddick, President of Innovation and Operations of Cirrus Aircraft.

Aristocrat Gaming™ Named an Official Partner of the New England Patriots and Gillette Stadium

Retrieved on: 
Tuesday, September 13, 2022
ASX, FIFA, Cambridge Innovation Center, Aristocrat Leisure, COVID-19, Twitter, FIFA World Cup, Patriot, NHL Winter Classic, Partner, NCAA, Creativity, NHL, Life, News, Partnership, Billboard, Industry, NFL, CEO, Technology, Instagram, Gillette, Gillette Stadium, New England Revolution, Class, ALL, Health, New England Patriots, 2020 New England Patriots season, Army–Navy Game, Sport, Amusement arcade, Facebook, Aristocracy (class), Pollstar

LAS VEGAS, Nev. and FOXBOROUGH, Mass., Sept. 13, 2022 /PRNewswire/ -- Aristocrat Gaming™ and the New England Patriots today announced a multi-year partnership making Aristocrat an Official Partner of the Patriots and Gillette Stadium. As an Official Partner, Aristocrat will have prominent signage throughout the stadium year-round, including in-stadium, on the concourse and in-game branding. Additional features will include in-game promotion and game-day activations.

Key Points: 
  • LAS VEGAS, Nev. and FOXBOROUGH, Mass., Sept. 13, 2022 /PRNewswire/ -- Aristocrat Gaming and the New England Patriots today announced a multi-year partnership making Aristocrat an Official Partner of the Patriots and Gillette Stadium.
  • As an Official Partner, Aristocrat will have prominent signage throughout the stadium year-round, including in-stadium, on the concourse and in-game branding.
  • "We are ecstatic to partner with the New England Patriots, one of the most successful and legendary franchises in the NFL," said Hector Fernandez, CEO of Aristocrat Gaming.
  • For more information on Aristocrat, and their partnership with the New England Patriots and Gillette Stadium, please visit www.aristocratgaming.com .